PCI 29732 - CAS 330786-25-9
Catalog number: 330786-25-9
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C22H21N5O
Molecular Weight:
371.44
COA:
Inquire
Targets:
BTK
Description:
Potent BTK inhibitor (IC50 = 0.3 nM). Blocks B cell antigen receptor (BCR)-mediated gene expression in CD20+ B cells.
Purity:
>98%
Synonyms:
PCI-29732; PCI 29732; PCI29732;
MSDS:
Inquire
InChIKey:
GMJUPMONHWAZCP-UHFFFAOYSA-N
InChI:
InChI=1S/C22H21N5O/c23-21-19-20(26-27(16-6-4-5-7-16)22(19)25-14-24-21)15-10-12-18(13-11-15)28-17-8-2-1-3-9-17/h1-3,8-14,16H,4-7H2,(H2,23,24,25)
Canonical SMILES:
C1CCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related BTK Products


CAS 1022150-12-4 Btk inhibitor 1 R enantiomer

Btk inhibitor 1 R enantiomer
(CAS: 1022150-12-4)

Btk inhibitor 1 R enantiomer is a pyrazolo[3,4-d]pyrimidine derivative as a Btk kinase inhibitor.

CAS 330786-25-9 PCI 29732

PCI 29732
(CAS: 330786-25-9)

Potent BTK inhibitor (IC50 = 0.3 nM). Blocks B cell antigen receptor (BCR)-mediated gene expression in CD20+ B cells.

CAS 1553977-42-6 Btk inhibitor 1 R enantiomer hydrochloride

Btk inhibitor 1 R enantiomer hydrochlori
(CAS: 1553977-42-6)

Btk inhibitor 1R enantiomer Hcl is a&nbsp; pyrazolo[3,4-d]pyrimidine derivative as a <strong>Btk </strong>kinase inhibitor.

CAS 1242156-23-5 RN486

RN486
(CAS: 1242156-23-5)

RN486 is a reversible Bruton's tyrosine kinase (Btk) inhibitor with IC50 value of 4.0 nM.

CAS 1415823-73-2 Evobrutinib

Evobrutinib
(CAS: 1415823-73-2)

Evobrutinib is a highly selective inhibitor of Bruton's tyrosin kinase (Btk) inhibitor.

CAS 936563-96-1 PCI-32765 (Ibrutinib)

PCI-32765 (Ibrutinib)
(CAS: 936563-96-1)

Ibrutinib is a small-molecule inhibitor of Bruton's tyrosine kinase (BTK). It binds to BTK to suppress both B-cell activation and B-cell-mediated signaling.

ONO-4059 analogue
(CAS: 1351635-67-0)

ONO-4059 analogue is an analogue of ONO-4059, which is a highly potent and selective oral BTK inhibitor with IC50 of 23.9 nM. Phase 1.

CAS 936563-87-0 PCI-32765 Racemate

PCI-32765 Racemate
(CAS: 936563-87-0)

PCI-32765 Racemate is a potent and highly selective inhibitor of Bruton tyrosine kinase (BTK), modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, ...

Chemical Structure

CAS 330786-25-9 PCI 29732

Quick Inquiry

Verification code

Featured Items